Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2013

01-11-2013 | Original Article

Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery

Authors: Christina Lampe, Christian Lampe, Manfred Schwarz, Wibke Müller-Forell, Paul Harmatz, Eugen Mengel

Published in: Journal of Inherited Metabolic Disease | Issue 6/2013

Login to get access

Abstract

Objective

To analyse diagnostic value of somato-sensory evoked potentials (SEP), magnetic resonance imaging (MRI), and clinical neurological examination in the decision for decompression surgery in mucopolysaccharidosis (MPS) VI patients with craniocervical cord compression (CCJ).

Methods

We retrospectively analysed neurological examination, SEP of the median nerve and MRI outcomes from 31 MPS VI patients. Individual scores for each test (based on severity of findings) and a sum of scores of all three procedures (CCJ score) were evaluated for their potential to measure the need for and improvement after surgery. Differences between rapidly and slowly progressive patients were also evaluated.

Results

Fourteen patients (45 %) aged 4–34 years underwent decompression surgery. Median age at first operation was lower in rapidly than in slowly progressive patients (12 vs. 24 years; P = 0.008). Neurological and SEP findings but not MRI results differed significantly between non-operated and operated patients (P < 0.001, P = 0.003 and P = 0.08, respectively). A significant relationship was found between MRI and clinical neurological examination (P < 0.001) and between SEP and clinical neurological examination (P = 0.01) but not between MRI and SEP (P = 0.06). The CCJ score discriminated between operated and non-operated patients (4–9 points vs. 0–3 points; P < 0.001) and decreased in 61.5 % of patients after surgery.

Conclusions

CCJ is common in rapidly and slowly progressive MPS VI patients. The CCJ score is an objective and transparent tool for assessing pathology of the CCJ, the need for surgery, and improvement after surgery.
Literature
go back to reference Boor R, Goebel B, Taylor MJ (1998) Subcortical somatosensory evoked potentials after median nerve stimulation in children. Eur J Paediatr Neurol 2:137–143PubMedCrossRef Boor R, Goebel B, Taylor MJ (1998) Subcortical somatosensory evoked potentials after median nerve stimulation in children. Eur J Paediatr Neurol 2:137–143PubMedCrossRef
go back to reference Boor R, Miebach E, Brühl K, Beck M (2000) Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses. Neuropediatrics 31:122–127PubMedCrossRef Boor R, Miebach E, Brühl K, Beck M (2000) Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses. Neuropediatrics 31:122–127PubMedCrossRef
go back to reference Gallegos-Arreola MP, Machorro-Lazo MV, Flores-Martínez SE et al (2000) Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses. Arch Med Res 31:505–510PubMedCrossRef Gallegos-Arreola MP, Machorro-Lazo MV, Flores-Martínez SE et al (2000) Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses. Arch Med Res 31:505–510PubMedCrossRef
go back to reference Giugliani R, Harmatz P, Wraith JE (2007) Management guidelines for mucopolysaccharidosis VI. Pediatrics 120:405–418PubMedCrossRef Giugliani R, Harmatz P, Wraith JE (2007) Management guidelines for mucopolysaccharidosis VI. Pediatrics 120:405–418PubMedCrossRef
go back to reference Kachur E, Del Maestro R (2000) Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 47:223–228PubMed Kachur E, Del Maestro R (2000) Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 47:223–228PubMed
go back to reference Lachman R, Martin KW, Castro S, Basto MA, Adams A, Teles EL (2010) Radiologic and neuroradiologic findings in the mucopolysaccharidoses. J Pediatr Rehabil Med 3:109–118PubMed Lachman R, Martin KW, Castro S, Basto MA, Adams A, Teles EL (2010) Radiologic and neuroradiologic findings in the mucopolysaccharidoses. J Pediatr Rehabil Med 3:109–118PubMed
go back to reference Mut M, Cila A, Varli K, Akalan N (2005) Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature. Clin Neurol Neurosurg 107:230–235PubMedCrossRef Mut M, Cila A, Varli K, Akalan N (2005) Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature. Clin Neurol Neurosurg 107:230–235PubMedCrossRef
go back to reference Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452 Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452
go back to reference Penning L, Wilmink JT, van Woerden HH, Knol E (1986) CT myelographic findings in degenerative disorders of the cervical spine: clinical significance. AJR Am J Roentgenol 146:793–801PubMedCrossRef Penning L, Wilmink JT, van Woerden HH, Knol E (1986) CT myelographic findings in degenerative disorders of the cervical spine: clinical significance. AJR Am J Roentgenol 146:793–801PubMedCrossRef
go back to reference Ratliff J, Voorhies R (2000) Increased MRI signal intensity in association with myelopathy and cervical instability: case report and review of the literature. Surg Neurol 53:8–13PubMedCrossRef Ratliff J, Voorhies R (2000) Increased MRI signal intensity in association with myelopathy and cervical instability: case report and review of the literature. Surg Neurol 53:8–13PubMedCrossRef
go back to reference Scarpa M, Buffone E, La Marca P, Campello M, Rampazzo A (2010) Difficulties in diagnosing slowly progressive mucopolysaccharidosis VI: a case series. J Pediatr Rehabil Med 3:71–75PubMed Scarpa M, Buffone E, La Marca P, Campello M, Rampazzo A (2010) Difficulties in diagnosing slowly progressive mucopolysaccharidosis VI: a case series. J Pediatr Rehabil Med 3:71–75PubMed
go back to reference Stöhr M, Dichgans J, Buettner UW, Hess W (eds) (2005) Evozierte potentiale. 4. Aufl. Springer, Berlin Stöhr M, Dichgans J, Buettner UW, Hess W (eds) (2005) Evozierte potentiale. 4. Aufl. Springer, Berlin
go back to reference Swiedler SJ, Beck M, Bajbouj M et al (2005) Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet 134A:144–150PubMedCrossRef Swiedler SJ, Beck M, Bajbouj M et al (2005) Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet 134A:144–150PubMedCrossRef
go back to reference Tamaki N, Kojima N, Tanimoto M, Suyama T, Matsumoto S (1987) Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case. Neurosurgery 21:416–419PubMedCrossRef Tamaki N, Kojima N, Tanimoto M, Suyama T, Matsumoto S (1987) Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case. Neurosurgery 21:416–419PubMedCrossRef
go back to reference Thorne JA, Javadpour M, Hughes DG, Wraith E, Cowie RA (2001) Craniovertebral abnormalities in type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 48:849–853PubMed Thorne JA, Javadpour M, Hughes DG, Wraith E, Cowie RA (2001) Craniovertebral abnormalities in type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 48:849–853PubMed
go back to reference Valayannopoulos V, Nicely H, Harmatz P, Turbeville S (2010) Mucopolysaccharidosis VI. Orphanet J Rare Dis 5:5PubMedCrossRef Valayannopoulos V, Nicely H, Harmatz P, Turbeville S (2010) Mucopolysaccharidosis VI. Orphanet J Rare Dis 5:5PubMedCrossRef
go back to reference Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, van Velthoven V (2001) Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 35:35–38PubMedCrossRef Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, van Velthoven V (2001) Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 35:35–38PubMedCrossRef
go back to reference Young R, Kleinman G, Ojemann RG et al (1980) Compressive myelopathy in Maroteaux-Lamy syndrome: clinical and pathological findings. Ann Neurol 8:336–340PubMedCrossRef Young R, Kleinman G, Ojemann RG et al (1980) Compressive myelopathy in Maroteaux-Lamy syndrome: clinical and pathological findings. Ann Neurol 8:336–340PubMedCrossRef
Metadata
Title
Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery
Authors
Christina Lampe
Christian Lampe
Manfred Schwarz
Wibke Müller-Forell
Paul Harmatz
Eugen Mengel
Publication date
01-11-2013
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2013
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9591-5

Other articles of this Issue 6/2013

Journal of Inherited Metabolic Disease 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.